{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:15:43Z","timestamp":1784546143706,"version":"3.55.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Aplastic anemia (AA) is a life-threatening bone marrow (BM) failure syndrome characterized by pancytopenia. Recent studies revealed that dysfunctional endothelial progenitor cells (EPCs), critical components of the BM microenvironment, are involved in hematopoietic-dysfunction-related diseases, including AA. However, the mechanism underlying EPC damage in AA remains unknown. Here we find that transforming growth factor-\u03b2 (TGF-\u03b2) signaling is hyperactive in dysfunctional AA EPCs with impaired hematopoietic support and immune regulatory ability, and TGF-\u03b2 inhibition promotes hematopoiesis and immune rebalance by repairing dysfunctional EPCs. Through impaired EPC and AA murine models, we validated that TGF-\u03b2 inhibition restores EPC dysfunction to improve hematopoiesis and immune status in vitro and in vivo. RNA sequencing and real-time quantitative polymerase chain reaction provided further validation. These results indicate that dysfunctional BM EPCs with hyperactive TGF-\u03b2 signaling are involved in AA. TGF-\u03b2 inhibition promotes multilineage hematopoiesis recovery and immune balance by repairing dysfunctional EPCs, providing a potential therapeutic strategy for AA.<\/jats:p>","DOI":"10.1038\/s12276-025-01483-4","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T15:23:09Z","timestamp":1751296989000},"page":"1324-1338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["TGF-\u03b2 inhibition restores hematopoiesis and immune balance via bone marrow EPCs in aplastic anemia"],"prefix":"10.1038","volume":"57","author":[{"given":"Xin-Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Zhu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5918-3003","authenticated-orcid":false,"given":"Zhong-Shi","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-2642","authenticated-orcid":false,"given":"Yuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"1483_CR1","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","volume":"108","author":"NS Young","year":"2006","unstructured":"Young, N. S., Calado, R. T. & Scheinberg, P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108, 2509\u20132519 (2006).","journal-title":"Blood"},{"key":"1483_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra1413485","volume":"379","author":"NS Young","year":"2018","unstructured":"Young, N. S. Aplastic anemia. N. Engl. J. Med. 379, 1643\u20131656 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1483_CR3","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1182\/blood-2018-05-844928","volume":"132","author":"W Sun","year":"2018","unstructured":"Sun, W. et al. Macrophage TNF-\u03b1 licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia. Blood 132, 2730\u20132743 (2018).","journal-title":"Blood"},{"key":"1483_CR4","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1182\/blood-2011-08-368308","volume":"119","author":"S Kordasti","year":"2012","unstructured":"Kordasti, S. et al. Functional characterization of CD4+ T cells in aplastic anemia. Blood 119, 2033\u20132043 (2012).","journal-title":"Blood"},{"key":"1483_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood.2020008966","volume":"138","author":"C Zhu","year":"2021","unstructured":"Zhu, C. et al. Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia. Blood 138, 23\u201333 (2021).","journal-title":"Blood"},{"key":"1483_CR6","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s11427-022-2310-x","volume":"66","author":"SQ Tang","year":"2023","unstructured":"Tang, S. Q. et al. Repair of dysfunctional bone marrow endothelial cells alleviates aplastic anemia. Sci. China Life Sci. 66, 2553\u20132570 (2023).","journal-title":"Sci. China Life Sci."},{"key":"1483_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2109965","volume":"386","author":"R Peffault de Latour","year":"2022","unstructured":"Peffault de Latour, R. et al. Eltrombopag added to immunosuppression in severe aplastic anemia. N. Engl. J. Med. 386, 11\u201323 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1483_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1182\/blood.2024024173","volume":"144","author":"J Montoro","year":"2024","unstructured":"Montoro, J. et al. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT. Blood 144, 323\u2013333 (2024).","journal-title":"Blood"},{"key":"1483_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41586-022-04571-x","volume":"604","author":"V Calvanese","year":"2022","unstructured":"Calvanese, V. et al. Mapping human haematopoietic stem cells from haemogenic endothelium to birth. Nature 604, 534\u2013540 (2022).","journal-title":"Nature"},{"key":"1483_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding, L., Saunders, T. L., Enikolopov, G. & Morrison, S. J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481, 457\u2013462 (2012).","journal-title":"Nature"},{"key":"1483_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","volume":"25","author":"T Sugiyama","year":"2006","unstructured":"Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12\u2013CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977\u2013988 (2006).","journal-title":"Immunity"},{"key":"1483_CR12","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1182\/blood-2008-06-162941","volume":"113","author":"AB Salter","year":"2009","unstructured":"Salter, A. B. et al. Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo. Blood 113, 2104\u20132107 (2009).","journal-title":"Blood"},{"key":"1483_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.stem.2010.02.001","volume":"6","author":"JM Butler","year":"2010","unstructured":"Butler, J. M. et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6, 251\u2013264 (2010).","journal-title":"Cell Stem Cell"},{"key":"1483_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.stem.2009.01.006","volume":"4","author":"AT Hooper","year":"2009","unstructured":"Hooper, A. T. et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 4, 263\u2013274 (2009).","journal-title":"Cell Stem Cell"},{"key":"1483_CR15","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1182\/blood-2006-05-022640","volume":"109","author":"JP Chute","year":"2007","unstructured":"Chute, J. P. et al. Transplantation of vascular endothelial cells mediates the hematopoietic recovery and survival of lethally irradiated mice. Blood 109, 2365\u20132372 (2007).","journal-title":"Blood"},{"key":"1483_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12013-012-9387-5","volume":"64","author":"L Zeng","year":"2012","unstructured":"Zeng, L. et al. Infusion of endothelial progenitor cells accelerates hematopoietic and immune reconstitution, and ameliorates the graft-versus-host disease after hematopoietic stem cell transplantation. Cell Biochem Biophys. 64, 213\u2013222 (2012).","journal-title":"Cell Biochem Biophys."},{"key":"1483_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1756-8722-6-61","volume":"6","author":"J Mai","year":"2013","unstructured":"Mai, J. et al. An evolving new paradigm: endothelial cells-conditional innate immune cells. J. Hematol. Oncol. 6, 61 (2013).","journal-title":"J. Hematol. Oncol."},{"key":"1483_CR18","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1161\/ATVBAHA.120.314330","volume":"40","author":"Y Shao","year":"2020","unstructured":"Shao, Y. et al. Vascular endothelial cells and innate immunity. Arterioscler Thromb. Vasc. Biol. 40, e138\u2013e152 (2020).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"1483_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/10245332.2018.1498566","volume":"23","author":"J Fang","year":"2018","unstructured":"Fang, J. et al. Regulatory T cells and CD20+ B cells in pediatric very severe aplastic anemia: possible clinical markers for evaluating the therapeutic efficacy and prognosis. Hematology 23, 823\u2013827 (2018).","journal-title":"Hematology"},{"key":"1483_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41536-024-00365-z","volume":"9","author":"M Hassanpour","year":"2024","unstructured":"Hassanpour, M., Salybkov, A. A., Kobayashi, S. & Asahara, T. Anti-inflammatory prowess of endothelial progenitor cells in the realm of biology and medicine. NPJ Regen. Med. 9, 27 (2024).","journal-title":"NPJ Regen. Med."},{"key":"1483_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1189\/jlb.3A0513-242R","volume":"96","author":"PM Chen","year":"2014","unstructured":"Chen, P. M. et al. Induction of immunomodulatory monocytes by human mesenchymal stem cell-derived hepatocyte growth factor through ERK1\/2. J. Leukoc. Biol. 96, 295\u2013303 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"1483_CR22","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2016-03-702803","volume":"128","author":"MM Shi","year":"2016","unstructured":"Shi, M. M. et al. Atorvastatin enhances endothelial cell function in posttransplant poor graft function. Blood 128, 2988\u20132999 (2016).","journal-title":"Blood"},{"key":"1483_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ajh.25056","volume":"93","author":"Y Kong","year":"2018","unstructured":"Kong, Y. et al. N-acetyl-l-cysteine improves bone marrow endothelial progenitor cells in prolonged isolated thrombocytopenia patients post allogeneic hematopoietic stem cell transplantation. Am. J. Hematol. 93, 931\u2013942 (2018).","journal-title":"Am. J. Hematol."},{"key":"1483_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1182\/blood-2017-09-807248","volume":"131","author":"Y Kong","year":"2018","unstructured":"Kong, Y. et al. Atorvastatin enhances bone marrow endothelial cell function in corticosteroid-resistant immune thrombocytopenia patients. Blood 131, 1219\u20131233 (2018).","journal-title":"Blood"},{"key":"1483_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03354-2","volume":"20","author":"T Xing","year":"2022","unstructured":"Xing, T. et al. Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes. J. Transl. Med. 20, 144 (2022).","journal-title":"J. Transl. Med."},{"key":"1483_CR26","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3324\/haematol.2021.279756","volume":"107","author":"ZS Lyu","year":"2022","unstructured":"Lyu, Z. S. et al. The glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage after chemotherapy and irradiation. Haematologica 107, 2365\u20132380 (2022).","journal-title":"Haematologica"},{"key":"1483_CR27","doi-asserted-by":"publisher","first-page":"216937","DOI":"10.1016\/j.canlet.2024.216937","volume":"592","author":"M Liang","year":"2024","unstructured":"Liang, M. et al. Activation of PPAR\u03b4 in bone marrow endothelial progenitor cells improves their hematopoiesis-supporting ability after myelosuppressive injury. Cancer Lett. 592, 216937 (2024).","journal-title":"Cancer Lett."},{"key":"1483_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02338-9","volume":"20","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Prophylactic NAC promoted hematopoietic reconstitution by improving endothelial cells after haploidentical HSCT: a phase 3, open-label randomized trial. BMC Med. 20, 140 (2022).","journal-title":"BMC Med."},{"key":"1483_CR29","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1182\/blood.V94.6.1961","volume":"94","author":"S Sakamaki","year":"1999","unstructured":"Sakamaki, S. et al. Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with high specificity. Blood 94, 1961\u20131970 (1999).","journal-title":"Blood"},{"key":"1483_CR30","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","volume":"147","author":"S Yamazaki","year":"2011","unstructured":"Yamazaki, S. et al. Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147, 1146\u20131158 (2011).","journal-title":"Cell"},{"key":"1483_CR31","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1182\/blood-2014-12-618090","volume":"125","author":"U Blank","year":"2015","unstructured":"Blank, U. & Karlsson, S. TGF-\u03b2 signaling in the control of hematopoietic stem cells. Blood 125, 3542\u20133550 (2015).","journal-title":"Blood"},{"key":"1483_CR32","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/nm.3706","volume":"20","author":"M Zhao","year":"2014","unstructured":"Zhao, M. et al. Megakaryocytes maintain homeostatic quiescence and promote post-injury regeneration of hematopoietic stem cells. Nat. Med. 20, 1321\u20131326 (2014).","journal-title":"Nat. Med."},{"key":"1483_CR33","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1084\/jem.20171477","volume":"215","author":"L Jiang","year":"2018","unstructured":"Jiang, L. et al. SHP-1 regulates hematopoietic stem cell quiescence by coordinating TGF-\u03b2 signaling. J. Exp. Med 215, 1337\u20131347 (2018).","journal-title":"J. Exp. Med"},{"key":"1483_CR34","doi-asserted-by":"publisher","first-page":"217290","DOI":"10.1016\/j.canlet.2024.217290","volume":"605","author":"ZK Wang","year":"2024","unstructured":"Wang, Z. K. et al. Inhibition of TGF-\u03b2 signaling in bone marrow endothelial cells promotes hematopoietic recovery in acute myeloid leukemia patients. Cancer Lett. 605, 217290 (2024).","journal-title":"Cancer Lett."},{"key":"1483_CR35","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1182\/blood.V74.5.1711.1711","volume":"74","author":"S Hayashi","year":"1989","unstructured":"Hayashi, S. et al. Differential effects of TGF-beta 1 on lymphohemopoiesis in long-term bone marrow cultures. Blood 74, 1711\u20131717 (1989).","journal-title":"Blood"},{"key":"1483_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.stem.2010.02.002","volume":"6","author":"GA Challen","year":"2010","unstructured":"Challen, G. A., Boles, N. C., Chambers, S. M. & Goodell, M. A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6, 265\u2013278 (2010).","journal-title":"Cell Stem Cell"},{"key":"1483_CR37","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1073\/pnas.1405546111","volume":"111","author":"R Qu\u00e9r\u00e9","year":"2014","unstructured":"Qu\u00e9r\u00e9, R. et al. Tif1\u03b3 regulates the TGF-\u03b21 receptor and promotes physiological aging of hematopoietic stem cells. Proc. Natl Acad. Sci. USA 111, 10592\u201310597 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1483_CR38","first-page":"943","volume":"20","author":"JA Carlino","year":"1992","unstructured":"Carlino, J. A. et al. Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. Exp. Hematol. 20, 943\u2013950 (1992).","journal-title":"Exp. Hematol."},{"key":"1483_CR39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0301-472X(00)00488-4","volume":"28","author":"Y Zermati","year":"2000","unstructured":"Zermati, Y. et al. Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp. Hematol. 28, 885\u2013894 (2000).","journal-title":"Exp. Hematol."},{"key":"1483_CR40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm.3512","volume":"20","author":"RN Suragani","year":"2014","unstructured":"Suragani, R. N. et al. Transforming growth factor-\u03b2 superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat. Med. 20, 408\u2013414 (2014).","journal-title":"Nat. Med."},{"key":"1483_CR41","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1182\/blood-2008-02-139824","volume":"112","author":"L Zhou","year":"2008","unstructured":"Zhou, L. et al. Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. Blood 112, 3434\u20133443 (2008).","journal-title":"Blood"},{"key":"1483_CR42","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nm.3468","volume":"20","author":"M Dussiot","year":"2014","unstructured":"Dussiot, M. et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in \u03b2-thalassemia. Nat. Med. 20, 398\u2013407 (2014).","journal-title":"Nat. Med."},{"key":"1483_CR43","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1182\/blood-2013-06-511238","volume":"123","author":"RN Suragani","year":"2014","unstructured":"Suragani, R. N. et al. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine \u03b2-thalassemia. Blood 123, 3864\u20133872 (2014).","journal-title":"Blood"},{"key":"1483_CR44","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1182\/blood-2018-10-879247","volume":"133","author":"A Piga","year":"2019","unstructured":"Piga, A. et al. Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with \u03b2-thalassemia. Blood 133, 1279\u20131289 (2019).","journal-title":"Blood"},{"key":"1483_CR45","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1182\/blood.2021012589","volume":"139","author":"G Garcia-Manero","year":"2022","unstructured":"Garcia-Manero, G. et al. Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial. Blood 139, 624\u2013629 (2022).","journal-title":"Blood"},{"key":"1483_CR46","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1016\/S2352-3026(22)00208-3","volume":"9","author":"AT Taher","year":"2022","unstructured":"Taher, A. T. et al. Luspatercept for the treatment of anaemia in non-transfusion-dependent \u03b2-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial. Lancet Haematol. 9, e733\u2013e744 (2022).","journal-title":"Lancet Haematol."},{"key":"1483_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0140-6736(23)00874-7","volume":"402","author":"U Platzbecker","year":"2023","unstructured":"Platzbecker, U. et al. Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial. Lancet 402, 373\u2013385 (2023).","journal-title":"Lancet"},{"key":"1483_CR48","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1016\/S2352-3026(24)00203-5","volume":"11","author":"MGD Porta","year":"2024","unstructured":"Porta, M. G. D. et al. Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial. Lancet Haematol. 11, e646\u2013e658 (2024).","journal-title":"Lancet Haematol."},{"key":"1483_CR49","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.stem.2016.03.002","volume":"18","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. TGF-\u03b2 inhibition rescues hematopoietic stem cell defects and bone marrow failure in fanconi anemia. Cell Stem Cell 18, 668\u2013681 (2016).","journal-title":"Cell Stem Cell"},{"key":"1483_CR50","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1172\/JCI125375","volume":"129","author":"CE Joyce","year":"2019","unstructured":"Joyce, C. E. et al. TGF\u03b2 signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman\u2013Diamond syndrome. J. Clin. Invest 129, 3821\u20133826 (2019).","journal-title":"J. Clin. Invest"},{"key":"1483_CR51","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2008-04-146480","volume":"113","author":"S Yamazaki","year":"2009","unstructured":"Yamazaki, S. et al. TGF-\u03b2 as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 113, 1250\u20131256 (2009).","journal-title":"Blood"},{"key":"1483_CR52","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41375-019-0420-1","volume":"33","author":"A Bataller","year":"2019","unstructured":"Bataller, A., Montalban-Bravo, G., Soltysiak, K. A. & Garcia-Manero, G. The role of TGF\u03b2 in hematopoiesis and myeloid disorders. Leukemia 33, 1076\u20131089 (2019).","journal-title":"Leukemia"},{"key":"1483_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1242\/jcs.113.3.383","volume":"113","author":"P Batard","year":"2000","unstructured":"Batard, P. et al. TGF-\u03b21 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J. Cell Sci. 113, 383\u2013390 (2000).","journal-title":"J. Cell Sci."},{"key":"1483_CR54","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1084\/jem.174.4.925","volume":"174","author":"J Hatzfeld","year":"1991","unstructured":"Hatzfeld, J. et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J. Exp. Med. 174, 925\u2013929 (1991).","journal-title":"J. Exp. Med."},{"key":"1483_CR55","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0092-8674(87)90294-7","volume":"49","author":"K Takehara","year":"1987","unstructured":"Takehara, K., LeRoy, E. C. & Grotendorst, G. R. TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell 49, 415\u2013422 (1987).","journal-title":"Cell"},{"key":"1483_CR56","doi-asserted-by":"publisher","first-page":"17260","DOI":"10.1073\/pnas.0605556103","volume":"103","author":"G Ferrari","year":"2006","unstructured":"Ferrari, G. et al. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl Acad. Sci. USA 103, 17260\u201317265 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1483_CR57","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2008.326","volume":"19","author":"MJ Goumans","year":"2009","unstructured":"Goumans, M. J., Liu, Z. & ten Dijke, P. TGF-beta signaling in vascular biology and dysfunction. Cell Res. 19, 116\u2013127 (2009).","journal-title":"Cell Res."},{"key":"1483_CR58","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans, M. J. et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta\/ALK5 signaling. Mol. Cell 12, 817\u2013828 (2003).","journal-title":"Mol. Cell"},{"key":"1483_CR59","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/emboj\/21.7.1743","volume":"21","author":"MJ Goumans","year":"2002","unstructured":"Goumans, M. J. et al. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J. 21, 1743\u20131753 (2002).","journal-title":"Embo J."},{"key":"1483_CR60","doi-asserted-by":"publisher","first-page":"a022210","DOI":"10.1101\/cshperspect.a022210","volume":"10","author":"MJ Goumans","year":"2018","unstructured":"Goumans, M. J. & Ten Dijke, P. TGF-\u03b2 signaling in control of cardiovascular function. Cold Spring Harb. Perspect. Biol. 10, a022210 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1483_CR61","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41589-021-00786-7","volume":"17","author":"C Dubiella","year":"2021","unstructured":"Dubiella, C. et al. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo. Nat. Chem. Biol. 17, 954\u2013963 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"1483_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04419-8","volume":"12","author":"E Delangre","year":"2021","unstructured":"Delangre, E. et al. Underlying mechanisms of glucocorticoid-induced \u03b2-cell death and dysfunction: a new role for glycogen synthase kinase 3. Cell Death Dis. 12, 1136 (2021).","journal-title":"Cell Death Dis."},{"key":"1483_CR63","doi-asserted-by":"publisher","first-page":"102677","DOI":"10.1016\/j.ebiom.2020.102677","volume":"53","author":"ZS Lyu","year":"2020","unstructured":"Lyu, Z. S. et al. Autophagy in endothelial cells regulates their haematopoiesis-supporting ability. EBioMedicine 53, 102677 (2020).","journal-title":"EBioMedicine"},{"key":"1483_CR64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.7150\/thno.30056","volume":"9","author":"F Deng","year":"2019","unstructured":"Deng, F. et al. Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer. Theranostics 9, 1001\u20131014 (2019).","journal-title":"Theranostics"},{"key":"1483_CR65","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","volume":"116","author":"WD Gray","year":"2015","unstructured":"Gray, W. D. et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ. Res 116, 255\u2013263 (2015).","journal-title":"Circ. Res"},{"key":"1483_CR66","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13045-018-0625-1","volume":"11","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties. J. Hematol. Oncol. 11, 82 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"1483_CR67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ebiom.2019.03.038","volume":"43","author":"W Xu","year":"2019","unstructured":"Xu, W. et al. Endothelial FAM3A positively regulates post-ischaemic angiogenesis. EBioMedicine 43, 32\u201342 (2019).","journal-title":"EBioMedicine"},{"key":"1483_CR68","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-021-00627-y","volume":"6","author":"HY Zhao","year":"2021","unstructured":"Zhao, H. Y. et al. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K\u2013AKT pathway activity. Signal Transduct. Target Ther. 6, 234 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1483_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.31129","volume":"239","author":"T Xing","year":"2024","unstructured":"Xing, T. et al. Bone marrow macrophages are involved in the ineffective hematopoiesis of myelodysplastic syndromes. J. Cell Physiol. 239, e31129 (2024).","journal-title":"J. Cell Physiol."},{"key":"1483_CR70","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1182\/blood.2022015474","volume":"140","author":"D Wang","year":"2022","unstructured":"Wang, D. et al. GARP-mediated active TGF-\u03b21 induces bone marrow NK cell dysfunction in AML patients with early relapse post-allo-HSCT. Blood 140, 2788\u20132804 (2022).","journal-title":"Blood"},{"key":"1483_CR71","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/cpr.12222","volume":"48","author":"S Lin","year":"2015","unstructured":"Lin, S. et al. TGF\u03b2 signalling pathway regulates angiogenesis by endothelial cells, in an adipose-derived stromal cell\/endothelial cell co-culture 3D gel model. Cell Prolif. 48, 729\u2013737 (2015).","journal-title":"Cell Prolif."},{"key":"1483_CR72","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.exphem.2004.08.006","volume":"32","author":"ML Bloom","year":"2004","unstructured":"Bloom, M. L. et al. A mouse model of lymphocyte infusion-induced bone marrow failure. Exp. Hematol. 32, 1163\u20131172 (2004).","journal-title":"Exp. Hematol."},{"key":"1483_CR73","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3324\/haematol.2017.163675","volume":"102","author":"X Feng","year":"2017","unstructured":"Feng, X. et al. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure. Haematologica 102, 1691\u20131703 (2017).","journal-title":"Haematologica"},{"key":"1483_CR74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.5396","volume":"251","author":"L Guo","year":"2020","unstructured":"Guo, L. et al. Characteristics, dynamic changes, and prognostic significance of TCR repertoire profiling in patients with renal cell carcinoma. J. Pathol. 251, 26\u201337 (2020).","journal-title":"J. Pathol."},{"key":"1483_CR75","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","volume":"54","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. Exp. Mol. Med. 54, 2060\u20132076 (2022).","journal-title":"Exp. Mol. Med."},{"key":"1483_CR76","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s12276-021-00714-8","volume":"53","author":"LL Xiong","year":"2021","unstructured":"Xiong, L. L. et al. Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer\u2019s disease. Exp. Mol. Med. 53, 1888\u20131901 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1483_CR77","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.immuni.2006.07.012","volume":"25","author":"JC Marie","year":"2006","unstructured":"Marie, J. C., Liggitt, D. & Rudensky, A. Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25, 441\u2013454 (2006).","journal-title":"Immunity"},{"key":"1483_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07075-w","volume":"12","author":"J Aarts","year":"2022","unstructured":"Aarts, J. et al. Local inhibition of TGF-\u03b21 signaling improves Th17\/Treg balance but not joint pathology during experimental arthritis. Sci. Rep. 12, 3182 (2022).","journal-title":"Sci. Rep."},{"key":"1483_CR79","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","volume":"26","author":"MO Li","year":"2007","unstructured":"Li, M. O., Wan, Y. Y. & Flavell, R. A. T cell-produced transforming growth factor-\u03b21 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26, 579\u2013591 (2007).","journal-title":"Immunity"},{"key":"1483_CR80","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1038\/s41375-021-01275-5","volume":"35","author":"M Wobus","year":"2021","unstructured":"Wobus, M. et al. Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells. Leukemia 35, 2936\u20132947 (2021).","journal-title":"Leukemia"},{"key":"1483_CR81","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1056\/NEJMoa1910182","volume":"382","author":"MD Cappellini","year":"2020","unstructured":"Cappellini, M. D. et al. A Phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia. N. Engl. J. Med. 382, 1219\u20131231 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1483_CR82","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ajh.27102","volume":"99","author":"MW Garbowski","year":"2024","unstructured":"Garbowski, M. W. et al. Luspatercept stimulates erythropoiesis, increases iron utilization, and redistributes body iron in transfusion-dependent thalassemia. Am. J. Hematol. 99, 182\u2013192 (2024).","journal-title":"Am. J. Hematol."},{"key":"1483_CR83","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1111\/jcmm.15243","volume":"24","author":"PA Martinez","year":"2020","unstructured":"Martinez, P. A. et al. Smad2\/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine \u03b2-thalassaemia by increasing GATA-1 availability. J. Cell Mol. Med. 24, 6162\u20136177 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"1483_CR84","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1182\/blood.2022017097","volume":"141","author":"S Lecomte","year":"2023","unstructured":"Lecomte, S. et al. Therapeutic activity of GARP:TGF-\u03b21 blockade in murine primary myelofibrosis. Blood 141, 490\u2013502 (2023).","journal-title":"Blood"},{"key":"1483_CR85","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1182\/blood-2018-11-876888","volume":"133","author":"P Fenaux","year":"2019","unstructured":"Fenaux, P., Kiladjian, J. J. & Platzbecker, U. Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis. Blood 133, 790\u2013794 (2019).","journal-title":"Blood"},{"key":"1483_CR86","doi-asserted-by":"crossref","unstructured":"Garcia-Manero G. et al. Multilineage and Safety Results From the COMMANDS Trial in Transfusion-Dependent, Erythropoiesis-Stimulating Agent-Naive Patients With Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes. EHA. P780 (2024).","DOI":"10.1016\/S2152-2650(24)00649-9"},{"key":"1483_CR87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00277-016-2821-9","volume":"96","author":"J Qiao","year":"2017","unstructured":"Qiao, J. et al. Endothelial progenitor cells improve the quality of transplanted hematopoietic stem cells and maintain longer term effects in mice. Ann. Hematol. 96, 107\u2013114 (2017).","journal-title":"Ann. Hematol."},{"key":"1483_CR88","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.cell.2024.04.009","volume":"187","author":"M Momenilandi","year":"2024","unstructured":"Momenilandi, M. et al. FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice. Cell 187, 2817\u20132837.e2831 (2024).","journal-title":"Cell"},{"key":"1483_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.217","volume":"49","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. IL-11 promotes the treatment efficacy of hematopoietic stem cell transplant therapy in aplastic anemia model mice through a NF-\u03baB\/microRNA-204\/thrombopoietin regulatory axis. Exp. Mol. Med. 49, e410 (2017).","journal-title":"Exp. Mol. Med."},{"key":"1483_CR90","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1182\/blood-2007-01-066258","volume":"110","author":"EE Solomou","year":"2007","unstructured":"Solomou, E. E. et al. Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia. Blood 110, 1603\u20131606 (2007).","journal-title":"Blood"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01483-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:02:27Z","timestamp":1751536947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01483-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":90,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01483-4","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}